Outbreaks of influenza cause considerable public health concerns and pose a potential threat of a global pandemic. In this paper, we describe some of our recent work on modeling of influenza virus with an IBM Blue Gene A supercomputer. The goal is to predict which mutations [on the viral glycoprotein hemagglutinin (HA)] are likely to occur in the next flu season, which mutations might escape antibody (Ab) neutralization, and which mutations might cause its receptor binding specificity to switch (e.g., from avian to human). We have analyzed more than 4,000 influenza A/H3N2 HA sequences from 1968 to 2010 to model the evolutionary path using a weighted mutual information method, which allows us to build a site transition network to predict antigenic drifts. We then used large-scale free energy perturbation calculations to study the mutation-induced effects on the antigen-Ab and antigen-receptor bindings. For example, we found that a single mutation T131I on H3N2 HA can decrease the HA-Ab binding affinity by 5.2 AE 0.9 kcal/mol, in excellent agreement with recent experimental results. We also found that a double mutation, i.e., V135S and A138S, could potentially switch the H5N1 HA binding specificity from avian to human, thus allowing the virus to gain a foothold in the human population. Detailed analyses also reveal a molecular picture of the influenza virus Ab and receptor binding mechanisms.
Introduction
The wide spread of influenza virus has become one of the most fatal diseases in humans and poultry [1] [2] [3] . The subtypes of A/H1N1, A/H3N2, and recent A/H5N1 have caused significant public health concerns due to the emergence of potential pandemic threats [4] [5] [6] [7] [8] [9] [10] . The viral surface glycoprotein hemagglutinin (HA) is the primary protein component of vaccines to provide protective immunity against influenza virus infection. However, the high mutation rates of HA ($ 5:7 Â 10 À3 substitutions per site per year) make it difficult to effectively predict future mutations and develop appropriate vaccines/antibodies for potential emerging pandemics [11] .
A number of studies aimed to understand the antigenic evolution of influenza caused by those mutations in HA [12] [13] [14] [15] [16] [17] [18] [19] . Smith et al. [20] have mapped the antigenic drift and the site mutations of H3N2 using the hemagglutination inhibition (HI) assays, which were the first to directly relate the viral genotype and the inferred phenotype [20] . Shih et al. [21] and later Du et al. [22] have found that antigenic drifts might be enhanced not only by the accumulation of single-site mutations but also by the simultaneous multi-site mutations of HA. Meanwhile, some key mutations that can escape antibody (Ab) neutralization have been revealed by binding affinity studies of H3N2 HA/Ab complex [5] . However, the current lack of H5N1 HA/Ab complex structure and limited binding affinity data of H3N2 HA/Ab present barriers to rigorous computer modeling approaches [23, 24] . Glycan array experiments allow qualitative estimation of the antigen-receptor binding affinity and identify mutations that might switch the H5N1 HA receptor binding specificity from avian (-2,3-linked sialylated glycan receptors) to human (-2,6-linked sialylated glycan receptors) [4, 6, 9, 25, 26] . However, conflicting results from different groups with slightly different glycan arrays indicate the limits of these techniques. Therefore, a better understanding of the genetic evolution paths of influenza virus, as well as accurate molecular modeling of the antigen-Ab and antigen-receptor bindings, is critical for subsequent development of effective vaccines against future strains. Rigorous modeling that yields sufficient accuracy is computationally demanding. We perform molecular simulations of binding affinities with the free-energy perturbation (FEP) method, which, in turn, uses large-scale molecular dynamics (MD) simulations to sample the conformational space.
We use an IBM Blue Gene* supercomputer to perform these computationally demanding tasks. The Blue Gene Watson* supercomputer is a state-of-the-art high-performance computing facility located at the IBM Thomas J. In this paper, we describe our recent work in order to provide a novel systematic approach to facilitate the development of influenza virus vaccine/Ab [17] [18] [19] . We begin with mapping the genetic evolution of influenza H3N2 virus by analyzing all available sequence data. A weighted mutual information (MI)-based machine-learning model is utilized to design a site transition network (STN) for each amino acid site of HA [18] . A novel five-step prediction algorithm based on this STN is used to predict the likely mutations that might occur in the next flu season. In the next step, we perform large-scale FEP calculations to quantitatively investigate the mutation-induced effects [17, 19, [27] [28] [29] [30] [31] . The current FEP calculations not only provide molecular mechanisms with detailed physical interactions but also identify potential mutations that might either escape Ab neutralization or switch the receptor binding specificity from avian to human [32, 33] . Identification of such key mutations could assist the development of vaccines in advance of the emergence of new strains. Detailed methods and results are reported and described in the following two sections.
Prediction of the antigenic variation of influenza virus
Network inference algorithm: Weighted MI We use a weighted MI approach to predict the antigenic evolution of influenza A virus [18, [34] [35] [36] [37] . The MI value for a pair of amino acid sites, i.e., x and y, can be defined as
wðx; yÞpðx; yÞ log pðx; yÞ pðxÞpðyÞ ;
where IðX ; Y Þ is the MI value; wðx; yÞ is the weighting factor (mutated sites have double the weight as nonmutated sites); and pðxÞ, pðyÞ, and pðx; yÞ in (1) are the probabilities associated with each discrete state, which are the probabilities of each residue to be mutated or not in our study.
We use A/H3N2 as an example to explain our model. The methodology developed here is equally applicable to H1N1 or H5N1 without any modification. All 4,311 HA1 full-length (9312 residue) sequences of A/H3N2 up to the release date of December 31, 2010 , are aligned before the MI calculation [sequence data were downloaded from the National Center for Biotechnology Information Influenza Virus Resource] [38] . We then divided the sequences into 43 bins according to the year information . Ten sequences from each bin were randomly selected to generate one sample input sequence in each calculation. A total of 2,000 different samples are randomly selected to gather sufficient statistics. The output MI matrices from these samples were normalized (with mean 0 and standard deviation of 1) to generate the final BMI matrix.[ The 2-D MI matrix obtained from the MI calculation includes the co-mutation correlation (MI value) for any pair of sites in HA1. A higher value between a pair of sites means a higher likelihood of co-mutation. An STN for all 312 sites can then be generated by the MI matrix. The nodes in the STN represent individual amino acid sites in HA1, and the edges between the two nodes represent the co-mutation correlation. An example of STN is shown in Figure 1 (a), in which 63 positive selection sites were selected and the edge with the normalized MI value lower than 0.5 was removed from the network [21] . The positive selection sites are thought to be responsible for the most antigenic variations. These are mainly distributed in the receptor binding domain and the five known epitopes. The effectiveness of the STN was evaluated by comparing STN with the Bantigenic maps[ from Smith et al. [20] . The antigenic map utilizes data from serum HI assays to measure the cross-immunity Bdistance[ between each strain of influenza to every other strain in an Bantigenic space.[ We found that the antigenic drift in A/H3N2 occurs more smoothly at a sequence level, which indicates that the mutation on antigenic sites of HA occurs all of the time and certain positive substitutions might result in a partial structural change in the antigenic regions. It seems that co-mutations and structural changes in a specific group of these sites may confer sufficient advantage to induce an antigenic change. To confirm this hypothesis, we performed further cluster analysis of the MI matrix (see below).
Co-mutation sites responsible for the antigenic drift
We applied a hierarchical clustering analysis to cluster mutation sites of HA1 in the MI matrix. The rationale behind this is that if any two sites i and j each have high MI values with some other common sites, they will all show high correlations and thus appear as a cluster. A total of five clusters were obtained from the cluster analysis, with each cluster representing roughly one or several antigenic transitions (see Table 1 ). For example, the mutations at sites 122, 207, and 188 responsible for the HK68-EN72 antigenic drift appear as a cluster. Such cluster analyses suggest that the sequence data alone, particularly for H3N2 where historical data is abundant, is adequate to uncover most of the antigenic variations of influenza virus. This finding implies that a cluster of co-mutating sites on HA1 might create large-enough structural change on the protein surface at antigenic sites to escape Ab neutralization and induce antigenic drift to a new strain.
STN-guided prediction of antigenic variation
The STN shows that antigenic drifts can be enhanced by cumulative co-occurring multi-site mutations in the epitope regions on the HA protein surface. These co-occurring mutations can be exploited to predict future mutations from the present network. Similarly, mutation hot spots can be identified by calculating the mutation frequency for each site of HA1. In addition, we observe nonrandom probabilities for different amino acid types at each mutation site. These strong preferences are a reflection of evolutionary selection.
A five-step algorithm has thus been designed to predict future antigenic variations (see Figure 2) . Before we start, we first define the year that we want to predict as the target year, i.e., N , and the years N À 1 and N À 2 as induction years. The steps in the prediction algorithm are listed as follows.
Step 1: Calculate all sites that are under positive selection in HA1 before year N . Here, the Bpositive selection site[ is defined as a site that has mutated in successive years and then remained fixed in the population for at least one year, similar to the definition used by Shih et al. [21] .
Step 2: Among the positive selection sites, find the sites that have just mutated in any of the induction years. Such sites are considered as the initial state of the present network.
Step 3: Use all of the available sequences before year N as a data source to construct the aforementioned sample sequence input file and calculate the MI matrix.
Step 4: Since the MI matrix quantifies the interaction between any two sites by a MI score, for each site X in HA1, we sum up the scores between the site X and all the sites found in Step 2 (i.e., newly mutated positive selection sites in induction years). The sites with high MI scores are chosen as predicted sites.
Step 5: Find the most probable amino acid type for each predicted mutation site from Step 4 by searching the historical amino acid type database for each site. Historical data suggests that there is a strong preference for each residue site to have some specific amino acid types (see the section BResults[). Therefore, we use the most probable amino acid type other than the current one as the final mutated type.
The five-step predictive method based on STN was then validated by testing the prediction accuracy of known years. The prediction of mutating sites was tested for every year from 1999 to 2008 using only the sequence data of prior years (thus, a blind test). We found that the accuracy of prediction was reasonably good and fairly stable, approximately 70% for most of the years tested, which means that the network-guided method can be a reliable tool to predict the antigenic variations. Figure 1(b) summarizes the statistical results and comparisons among various methods, i.e., the weighted MI method, the normal MI (unweighted) method, and a random selection method. Obviously, the weighted MI method performs best, whereas the random selection method is not predictive, as one would expect.
Following the same procedure for the above validations, we used all the sequence data available up to year 2010 to predict likely mutations in year 2011. Our method predicted six possible mutation sites, i.e., N6I, N121I, Table 1 Amino acid sites responsible for co-occurring mutations. A total of five clusters were obtained from the cluster analysis, with each cluster representing roughly one or several antigenic transitions. The sites shown in red in rows 2 and 3 are the identical sites obtained from both the real historical data and our clustering analysis (and the ones in gray are missed ones).
Figure 2
Five-step prediction algorithm based on STN.
R142G, N144V, I192T, and R261H, that may appear in the next flu season. These predictions will be validated against actual strains in due course, as 2011 strains are sequenced and the sequence information is released. These predictions can also be used as starting points in structural modeling of antigen-Ab and antigen-receptor binding affinities in order to computationally forecast the consequences of these mutations.
Modeling of receptor specificity and escape from Ab neutralization

Large-scale FEP with Blue Gene Watson
The FEP method has been widely used to calculate binding affinities for a variety of biophysical phenomena such as solvation free energy values, enzyme catalysis, redox, pKa, ion conductance, ligand-receptor binding, protein-protein interaction, and protein-nucleic acid binding [27-29, 31-33, 39-47] . A thermodynamic cycle is often employed to estimate the relative free energy change ðÁÁGÞ caused by a mutation ðA ! B : ÁG B À ÁG A Þ, since the absolute binding free energy is usually very difficult to directly calculate in FEP simulations. We follow a similar approach as in previous studies and design a thermodynamic cycle, as shown in Figure 3 , to calculate the relative binding affinities of the bound ðÁG 1 : antigen þ antibodyÞ and free states (ÁG 2 : antigen only) (for details, see our previous publications, i.e., [17] and [19] ). The total free energy change should be zero in any thermodynamic cycle, i.e.,
which gives the binding affinity change due to the mutation from A to B as
where ÁG 1 , ÁG 2 , ÁG A , and ÁG B are the free energy changes defined above. Among several available computational methods developed in the past years, FEP using an all-atom explicit solvent model serves as the most accurate approach for our current needs in estimating the relative antigen-Ab and antigen-receptor binding affinities [45, 47] . Such simulations for realistically sized biological systems often require large computational resources [48] [49] [50] [51] [52] [53] [54] . Here, we have utilized the massively parallel MD software developed on IBM Blue Gene to perform these FEP calculations [48] [49] [50] [51] [52] [53] .
Escape from Ab neutralization
The accuracy of FEP calculations was first validated by introducing an experimentally known mutation T131I [5] . This T131I single mutation in H3N2 HA can increase the Ab-antigen dissociation constant K d by a factor of approximately 4,000 (equivalent to a binding affinity decrease of À5 kcal/mol), thus causing an escape of the Ab neutralization [5] . Our FEP calculation using the IBM Blue Gene supercomputer estimated the HA-Ab binding affinity decrease of 5.2 AE 0.9 kcal/mol, which is in excellent agreement with the experimental results. The decomposition of the total binding affinity revealed that the electrostatic interactions dominate the free energy change, with about 70% from electrostatic and 30% from van der Waals interactions. The physicochemical factors behind the FEP results were also investigated in atomic detail. Two or more bridging water molecules were constantly found between the wild-type HA and the Ab near residue T131 in the simulation [see Figure 4(a) ]. These bridge water molecules form hydrogen bonds with the HA T131 side chain's hydroxyl group and the Ab fragment (Fab) heavy chain residues (hydroxyl group or backbone), such as sites Y107, S31, and A53. These water molecules appear to be lubricants at the Ab-antigen interface; the water molecules were not fixed in space but fairly mobile with hydrogen bonds forming and breaking all the time. During the FEP simulation, the T131 was gradually mutated to I (Ile); the much bulkier hydrophobic side chain of I131 displaces these two or three bridging water molecules [see Figure 4 (b)]. Therefore, the displacement of bridge water molecules from the binding site has contributed to the loss of the binding affinity in the T131I mutation [17] .
In addition to the T131I mutation, another 14 neutral mutations and 4 charged ones were also performed at the same site 131. All of the binding affinity changes with standard deviations are listed in Table 2 . For the neutral residue mutations, T131W, T131Y, and T131F are found to have even larger binding affinity decreases, with ÁÁG values of 7.46 AE 1.91, 6.01 AE 1.31, and 5.68 AE 1.48 kcal/mol, respectively. These mutations also reveal a significant displacement of bridging water molecules. Other residues such as T131H (3.84 kcal/mol), T131L (3.15 kcal/mol), T131N (2.92 kcal/mol), T131V (2.58 kcal/mol), and T131Q (1.22 kcal/mol) also show a decrease in the binding affinity. Meanwhile, a few others show an increase in the binding energy, such as T131G (À3.72 kcal/mol), T131A (À2.81 kcal/mol), and T131S (À0.48 kcal/mol). The smaller sizes of mutated residues Gly (G) and Ala (A) seem to have accommodated more bridging water molecules (three to four water molecules) in the active site, as well as less Bsteric repulsion[ in the relatively flat binding pocket, resulting in a more favorable binding. Interestingly, the T131A mutation was observed in 1990, and then, a back-mutation A131T was observed in 1994, indicating that it is not a favorable mutation for the virus [21] . Although we are not suggesting that this binding affinity increase is the only reason for this back A131T mutation, our FEP simulation is consistent with the real-world influenza A/H3N2 virus evolution in this instance. All of the mutations to charged residues show a decrease in binding affinity. The negatively charged residues (T131D and T131E) have a significantly larger decrease than the basic residues (T131K and T131R). This is because the nearby acidic residue D98 from the Ab heavy chain contributes favorable electrostatic interaction with K131 and R131.
Receptor binding specificity modeling The high pathogenicity and human mortality rates of H5N1 virus infections have raised serious public health concerns that this virus may seed the next pandemic. The determining factor to the host specificity of influenza viruses is thought Figure 4 Bridging water between T131 and the Ab: (a) bridging water in native T131-Ab complex; (b) bridging water disappeared at the end of the T131I mutation. The bridge water and hydrogen-bonding residues A53 and Y107 from Ab are shown with sticks. The T131I residue is colored by dual topology (red: T131; blue: I131). (Reproduced from [17] , with permission.) to be the linkage between sialic acids (SAs) and the penultimate sugar in the host cell receptors [55] [56] [57] [58] . A switch in the receptor specificity from -2,3-linked to -2,6-linked sialylated glycans is believed to facilitate bird-to-human, as well as human-to-human, transmission of influenza viruses [56, 57, [59] [60] [61] . Unfortunately, the HA-SA binding affinity at each HA monomer level is only in millimolars (i.e., a few kilocalories per mole), which poses a significant challenge for computer modeling, since the thermal fluctuations can be easily seen at kT level ($0.6 kcal/mol at body temperature). In this paper, we again use the IBM Blue Gene supercomputer to carry out large-scale FEP calculations to investigate the HA-glycan binding at the atomic level and identify likely mutations in currently circulating H5N1 influenza viruses that may be critical for binding to human receptors. The goal is to characterize the effect of mutations on HA-glycan binding specificity [17, [27] [28] [29] [30] [31] .
Similar to the FEP simulation for Ab-HA, the simulation protocol was also validated by comparing the simulated binding affinities to experimentally available data [6, 9, 25] . The simulated binding affinities agree fairly well with currently available glycan array data for several H5 HA mutants. Then, a number of single/double amino acid mutations were performed at position 135 and/or 138 to find mutations causing such a switch in the H5 HA receptor specificity from -2,3-glycan (avian) to -2,6-glycan (human) [19] . Overall, the binding affinities for those mutations suggest that the majority of them results in either no change or a decrease in binding affinity to -2,6-glycan over -2,3-glycan. However, V135S and A138S single mutations result in a small preference for -2,6-glycan, with a ÁÁG of À0:6 AE 0:19 kcal/mol for V135S and À0:41 AE 0:32 kcal/mol for A138S (see Table 3 ). Table 3 Receptor binding free energy changes of avian H5 HA on a number of mutations at V135 and A138. The results for V135S and A138S double mutations are in red.
Figure 5
Conformational change observed in the free state of modeled avian H5 HA on the (V135S and A138S) double mutation. The backbone of the wild-type protein is shown in yellow, whereas the backbone of the double mutant protein is shown in cyan. Side chains are shown for the two mutation sites, i.e., 135 and 138, in addition to the residues E190, K193, K222, N224, and Q226. Clearly, introduction of the double mutation alters the conformation of the receptor binding pocket of H5 HA, which significantly facilitates human receptor binding. (Reproduced from [19] , with permission.)
The double mutation (V135S and A138S) in H5 HA significantly enhances the human receptor binding by ÁÁG ¼ À2:56 AE 0:73 kcal/mol over the avian one ðÁÁG ¼ 0:84 AE 1:02 kcal/molÞ. Simulating the same double mutation in another H5 HA-receptor complex, the Sing97 virus has reproduced this effect, where this double mutation also shows a substantial increase in the human receptor binding ðÁÁG ¼ À1:18 AE 0:57 kcal/molÞ over the avian one ðÁÁG ¼ À0:15 AE 0:99 kcal/molÞ. Considering that the HA-glycan binding is weak in general, a À2.56 kcal/mol relative binding free energy change per monomer of H5 HA should be regarded as a strong indication for a substantial increase in HA receptor binding affinity. A free energy component analysis indicates that the electrostatic interactions dominate the contribution to the free energy change associated with human receptor binding of the double V135S and A138S mutant ($80% from electrostatic and $20% from van der Waals interactions). A structural analysis offers further explanation of why the double mutant prefers the human receptor (see Figure 5) . The HA-glycan hydrogen-bonding network is rearranged in the double V135S and A138S mutant. Residues Y95, S135, S136, S137, E190, K222, G225, and Q226 of this altered receptor binding domain form favorable hydrogen-bonding interactions with the human-like receptor, similar to the human-adapted HAs. In addition, the crucial presence of S138 in human H1 HA further emphasizes the significance of this predicted double mutant of avian H5 HA in gaining pandemic potential.
Conclusion
In summary, we have proposed a novel systematic approach to facilitate the development of vaccines against influenza virus (see Figure 6 ) [17] [18] [19] . We first use machine-learning techniques to predict likely mutations that might occur in the next flu season. A weighted MI algorithm is developed to capture the nonlinear correlation for each amino acid site of HA. Then, the variations at the predicted sites of mutation could be structurally modeled in order to investigate the consequence of these mutations. A few examples have been provided for the antigen-Ab and antigen-receptor binding affinity calculations. These advanced structural modeling and simulations provide detailed atomistic mechanisms and help identify potential mutations that could escape Ab neutralization or switch the receptor specificity from avian to human. Overall, our comprehensive approach could provide potent leads for the design of future vaccines against influenza virus. 
